Zura Bio Ltd SEC filings ZURA
Zura Bio Ltd has 446 filings in SEC EDGAR's recent list, going back to Apr 8, 2021. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 27, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Nov 3, 2026 | — |
| S-3 | Shelf registration | Oct 27, 2026 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 27, 2026 | Oct 27, 2026 |
| 10-Q | Quarterly report | Oct 27, 2026 | Sep 30, 2026 |
| S-8 | Employee stock plan registration | Sep 30, 2026 | — |
| 144 | Notice of proposed sale | Aug 18, 2026 | — |
| 144 | Notice of proposed sale | Aug 17, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 17, 2026 | Aug 17, 2026 |
| 144 | Notice of proposed sale | Aug 14, 2026 | — |
| 144 | Notice of proposed sale | Aug 13, 2026 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 11, 2026 | Aug 11, 2026 |
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 1, 2026 | Jul 1, 2026 |
| 3 | Initial insider ownership | Jun 22, 2026 | Apr 17, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 18, 2026 | Jun 17, 2026 |
| DEFA14A | Additional proxy material | May 22, 2026 | — |
| 8-K |
Current report
Officer or director change
|
May 22, 2026 | May 20, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 12, 2026 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 7, 2026 | May 7, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 6, 2026 | — |
| ARS | Annual report to shareholders | Apr 30, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Apr 30, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 23, 2026 | Apr 20, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Apr 1, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Apr 1, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Apr 1, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Apr 1, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Apr 1, 2026 |
| 10-K | Annual report | Mar 19, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 19, 2026 | Mar 19, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2026 | Mar 10, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Feb 21, 2026 |
| 3 | Initial insider ownership | Mar 5, 2026 | Feb 21, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 5, 2026 | Mar 5, 2026 |
| 4 | Insider transaction | Mar 2, 2026 | Feb 26, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Mar 2, 2026 | — |
| 8-K/A | Amended current report | Feb 26, 2026 | Feb 24, 2026 |
| 8-K |
Current report
Material agreement, Results of operations, Other events
|
Feb 26, 2026 | Feb 24, 2026 |
| 424B5 | Prospectus supplement | Feb 25, 2026 | — |
| 4 | Insider transaction | Feb 24, 2026 | Feb 21, 2026 |
| 3 | Initial insider ownership | Feb 24, 2026 | Feb 21, 2026 |
| 424B5 | Prospectus supplement | Feb 24, 2026 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Feb 23, 2026 | Feb 21, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 11, 2026 | Feb 11, 2026 |
| 4 | Insider transaction | Jan 27, 2026 | Jan 23, 2026 |
| 3 | Initial insider ownership | Jan 27, 2026 | Jan 23, 2026 |
| SCHEDULE 13D | Ownership over 5% (active) | Jan 27, 2026 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 26, 2026 | Jan 20, 2026 |
| 4 | Insider transaction | Jan 23, 2026 | Jan 21, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 12, 2026 | Jan 12, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 2, 2026 | — |
| 3 | Initial insider ownership | Jan 2, 2026 | Dec 29, 2025 |
| 8-K |
Current report
Material agreement, Agreement ended, Unregistered share sale, Other events
|
Jan 2, 2026 | Dec 29, 2025 |
| 8-K |
Current report
Officer or director change
|
Dec 17, 2025 | Dec 11, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2025 | Nov 13, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 10, 2025 | Oct 8, 2025 |
| 8-K |
Current report
Officer or director change
|
Sep 30, 2025 | Sep 24, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 4, 2025 | Sep 4, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 20, 2025 | Aug 20, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2025 | Aug 14, 2025 |
| 4 | Insider transaction | Jul 17, 2025 | Jul 15, 2025 |
| 3 | Initial insider ownership | Jul 17, 2025 | Jul 7, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 16, 2025 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 1, 2025 | Jun 25, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 4, 2025 | Jun 4, 2025 |
| UPLOAD | Letter from the SEC | Jun 3, 2025 | — |
| 4 | Insider transaction | May 29, 2025 | May 29, 2025 |
| 3 | Initial insider ownership | May 29, 2025 | May 21, 2025 |
| SCHEDULE 13D | Ownership over 5% (active) | May 28, 2025 | — |
| 3 | Initial insider ownership | May 28, 2025 | May 21, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
May 27, 2025 | May 27, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 23, 2025 | May 21, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 21, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 21, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 21, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 21, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 21, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 21, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 21, 2025 |
| CORRESP | Letter to the SEC | May 22, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
May 20, 2025 | May 20, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 14, 2025 | — |
| 4 | Insider transaction | May 12, 2025 | May 8, 2025 |
| UPLOAD | Letter from the SEC | May 8, 2025 | — |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| ARS | Annual report to shareholders | Apr 23, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Apr 23, 2025 | May 21, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Apr 17, 2025 | Apr 16, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 25, 2025 | Mar 25, 2025 |
| 10-K | Annual report | Mar 25, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 25, 2025 | Mar 25, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Feb 27, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Feb 27, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Feb 27, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Feb 27, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 24, 2025 | Feb 24, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 5 | Annual insider ownership | Feb 14, 2025 | Dec 31, 2024 |
| 5 | Annual insider ownership | Feb 14, 2025 | Dec 31, 2024 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 12, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 4 | Insider transaction | Dec 31, 2024 | Oct 1, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 23, 2024 | Dec 23, 2024 |
| 4 | Insider transaction | Dec 11, 2024 | Dec 9, 2024 |
| 4 | Insider transaction | Dec 11, 2024 | Dec 9, 2024 |
| 4 | Insider transaction | Dec 11, 2024 | Dec 9, 2024 |
| 4 | Insider transaction | Dec 11, 2024 | Dec 9, 2024 |
| 4 | Insider transaction | Dec 11, 2024 | Dec 9, 2024 |
| 4 | Insider transaction | Dec 11, 2024 | Dec 9, 2024 |
| 4 | Insider transaction | Dec 11, 2024 | Dec 9, 2024 |
| 4 | Insider transaction | Dec 11, 2024 | Dec 9, 2024 |
| 4 | Insider transaction | Dec 11, 2024 | Dec 9, 2024 |
| 4 | Insider transaction | Nov 27, 2024 | Nov 25, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 25, 2024 | Nov 25, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 14, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 14, 2024 | Nov 14, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 30, 2024 | Oct 30, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Oct 29, 2024 | Oct 23, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 18, 2024 | Oct 15, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Sep 23, 2024 | — |
| EFFECT | Filing | Sep 17, 2024 | — |
| CORRESP | Letter to the SEC | Sep 16, 2024 | — |
| S-3/A | Form s-3/a | Sep 16, 2024 | — |
| ARS | Annual report to shareholders | Sep 13, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Sep 13, 2024 | — |
| DEF 14A | Proxy statement | Sep 13, 2024 | Oct 23, 2024 |
| 4 | Insider transaction | Sep 13, 2024 | Sep 11, 2024 |
| S-3/A | Form s-3/a | Sep 11, 2024 | — |
| EFFECT | Filing | Sep 10, 2024 | — |
| EFFECT | Filing | Sep 10, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 10, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 9, 2024 | Sep 9, 2024 |
| 4/A | Filing | Sep 9, 2024 | Apr 22, 2024 |
| 4 | Insider transaction | Sep 6, 2024 | Sep 4, 2024 |
| 4/A | Filing | Sep 6, 2024 | Apr 22, 2024 |
| 4/A | Filing | Sep 6, 2024 | Apr 22, 2024 |
| 4/A | Filing | Sep 6, 2024 | Apr 22, 2024 |
| POS AM | Filing | Sep 5, 2024 | — |
| POS AM | Filing | Sep 5, 2024 | — |
| 144 | Notice of proposed sale | Sep 4, 2024 | — |
| S-3 | Shelf registration | Sep 3, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 3, 2024 | Sep 3, 2024 |
| 25-NSE | Delisting notice | Aug 27, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Aug 21, 2024 | Aug 15, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 14, 2024 | Aug 14, 2024 |
| 424B3 | Prospectus | Aug 13, 2024 | — |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2024 | Aug 13, 2024 |
| 425 | Filing | Aug 12, 2024 | — |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Shareholder vote results, Other events
|
Aug 12, 2024 | Aug 12, 2024 |
| SC TO-I/A | Filing | Aug 9, 2024 | — |
| 425 | Filing | Aug 9, 2024 | — |
| 8-K |
Current report
Other events
|
Aug 9, 2024 | Aug 9, 2024 |
| EFFECT | Filing | Aug 8, 2024 | — |
| 424B3 | Prospectus | Aug 8, 2024 | — |
| 4 | Insider transaction | Aug 8, 2024 | May 18, 2024 |
| CORRESP | Letter to the SEC | Aug 6, 2024 | — |
| CORRESP | Letter to the SEC | Jul 25, 2024 | — |
| SC TO-I/A | Filing | Jul 25, 2024 | — |
| S-4/A | Filing | Jul 25, 2024 | — |
| 425 | Filing | Jul 25, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Jul 25, 2024 | Jul 24, 2024 |
| UPLOAD | Letter from the SEC | Jul 19, 2024 | — |
| 425 | Filing | Jul 12, 2024 | — |
| 8-K |
Current report
Other events
|
Jul 12, 2024 | Jul 12, 2024 |
| SC TO-I | Filing | Jul 12, 2024 | — |
| S-4 | Registration for a merger or exchange | Jul 12, 2024 | — |
| 8-K/A |
Amended current report
Officer or director change
|
Jul 2, 2024 | Mar 24, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 18, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 18, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 18, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 18, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 18, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ZURA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- La Jolla, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1855644
- Former names
- JATT Acquisition Corp (until Mar 21, 2023)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.